about
TWEAK attenuates the transition from innate to adaptive immunityA soluble BAFF antagonist, BR3-Fc, decreases peripheral blood B cells and lymphoid tissue marginal zone and follicular B cells in cynomolgus monkeysGenetic deletion of JAM-C reveals a role in myeloid progenitor generationRequirement for coronin 1 in T lymphocyte trafficking and cellular homeostasisFgf-10 is required for both limb and lung development and exhibits striking functional similarity to Drosophila branchlessInterleukin-22 mediates early host defense against attaching and effacing bacterial pathogensInterleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisPolar solvents decrease the viscosity of high concentration IgG1 solutions through hydrophobic solvation and interaction: formulation and biocompatibility considerations.The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice.Proliferative and non-proliferative lesions of the rat and mouse integument.Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds.Actin-bundling protein L-plastin regulates T cell activation.New strategies for the prevention of radiation injury: possible implications for countering radiation hazards of long-term space travel.Growth factors in porcine full and partial thickness burn repair. Differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor.Minipig as a potential translatable model for monoclonal antibody pharmacokinetics after intravenous and subcutaneous administration.B-cell activation influences T-cell polarization and outcome of anti-CD20 B-cell depletion in central nervous system autoimmunityIL-22R Ligands IL-20, IL-22, and IL-24 Promote Wound Healing in Diabetic db/db MiceAnti-CD22 and anti-CD79b antibody-drug conjugates preferentially target proliferating B cells.IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.Therapeutic Antibody-Induced Vascular Toxicity Due to Off-Target Activation of Nitric Oxide in Cynomolgus Monkeys.Investigation of epidermotropism in canine mycosis fungoides: expression of intercellular adhesion molecule-1 (ICAM-1) and beta-2 integrins.Stimulation of all epithelial elements during skin regeneration by keratinocyte growth factor.Nonselective inhibition of the epigenetic transcriptional regulator BET induces marked lymphoid and hematopoietic toxicity in mice.Recombinant rat fibroblast growth factor-16: structure and biological activity.An Overview of the Pathogenesis of Immune-mediated Skin Injury.Preclinical Safety Profile of a Depleting Antibody against CRTh2 for Asthma: Well Tolerated Despite Unexpected CRTh2 Expression on Vascular Pericytes in the Central Nervous System and Gastric Mucosa.In Vitro Skin Models and Their Predictability in Defining Normal and Disease Biology, Pharmacology, and Toxicity.Combined treatment of acute EAE in Lewis rats with TNF-binding protein and interleukin-1 receptor antagonist.A brief overview of the 32nd Annual STP Symposium on the Toxicologic Pathology of the Digestive Tract and Pancreas.A brief overview of the 32nd Annual STP Symposium on the Toxicologic Pathology of the Digestive Tract and Pancreas.Effect of recombinant human keratinocyte growth factor (rHuKGF) on the immunopathogenesis of intestinal graft-vs.-host disease induced without a preconditioning regimen.DCDT2980S, an anti-CD22-monomethyl auristatin E antibody-drug conjugate, is a potential treatment for non-Hodgkin lymphoma.Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease.Nonclinical safety assessment of a human interleukin-22FC IG fusion protein demonstrates in vitro to in vivo and cross-species translatabilityThe Effects of IL-20 Subfamily Cytokines on Reconstituted Human Epidermis Suggest Potential Roles in Cutaneous Innate Defense and Pathogenic Adaptive Immunity in PsoriasisProtection from thymic epithelial cell injury by keratinocyte growth factor: a new approach to improve thymic and peripheral T-cell reconstitution after bone marrow transplantationKeratinocyte growth factor preserves normal thymopoiesis and thymic microenvironment during experimental graft-versus-host diseaseAnti-BR3 antibodies: a new class of B-cell immunotherapy combining cellular depletion and survival blockadeEvidence for an asialoglycoprotein receptor on nonparenchymal cells for O-linked glycoproteinsPharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers
P50
Q28284920-929338C4-0C48-4CF6-9ED4-B6C324BFE863Q28293722-0B6F74AC-695C-414D-AB16-615973F1FE88Q28504832-2840E87D-8CE9-49F8-B94A-55DB9318675AQ28508705-DE6E9F97-9DD3-484B-AA9B-E1ECAFE3B758Q28589182-AAE9ACD3-6E72-489F-BFF1-32D7B83619D0Q29617432-36E2442F-8686-4676-8811-8C8E28173AEDQ29620506-5AD8F514-522E-44A0-9D33-BC9C07ED8A45Q30426459-F6F64DA7-A8D0-4FFC-92A6-E3450DA20349Q33490078-C531396C-EF3D-45EC-80A8-17F1445C6658Q33880072-B53508D5-8CCF-4BD3-9C6A-5C045CA21650Q34203118-809ECBCA-A283-4E49-9819-B8A166C67E07Q34522338-AA95AED0-0524-4D95-9849-2B102319401AQ35148207-33D818C6-CC82-4314-9BE1-8675F268BD76Q35795536-7BDF3582-4F7C-41C5-8620-44BCBDA22BC0Q35992509-8A2A0349-4CF9-4FD8-B1C4-FF46FF90C8C1Q36034499-0B85A920-F8F0-4172-B9C9-4A81EE98FA93Q36261228-B6BD4A14-BD8F-4863-AE4B-893968B4121BQ37723164-D6FF3A4E-2211-47F5-8A59-CFE9DB1B646DQ39727345-A5EFC97A-498C-4058-9D97-8337F895B6D1Q39966848-91AFD2A5-27C1-426C-872C-F2047C9146B0Q41665929-69BB308C-3F43-4AD0-B6FC-23769195F01AQ42475606-BE320F7B-E6A9-44C9-900D-E41D84B63595Q42698125-478706C3-2681-46F8-9B61-E4D64E6E16D6Q42822853-5310F7D8-343A-496E-8C99-90200CCA8432Q45979186-1212937A-903E-4BB9-A627-81D977465A1DQ46113413-4A1A08A8-ABDD-49EA-8986-68CCF354740CQ46194057-8FB38BC7-9AB0-4736-B9DB-77DF133F2255Q46349911-25CD5A25-FDF0-4620-8703-A30269DFA7A9Q46680786-5E33E2E1-DE6C-46EC-9471-A9C1D7CC5EF9Q46944343-4B9B287B-CAEC-4B89-B413-2B912DEC7CDAQ47943611-AE979632-8B7E-4D4C-B8C7-8CFA1523A8F5Q51061692-74323AF2-83FC-4897-9C3C-83684995DBCDQ52618987-E8ED0A93-18C9-4648-B497-0CCB0DE5A0B1Q59134894-4CD05B9C-C718-447C-B668-38D43DE3ED19Q61356960-DAF00235-72EF-4DCA-ADDE-625165BD70E3Q74198793-060EA265-EE46-4C49-9715-589EFA37B8AEQ74389162-79D884A2-71DB-4C5F-A313-C8E88B285D70Q80768340-4B61CCFC-C438-4FA3-9F9F-A20514A8AAB9Q81830019-B6E198B4-384A-4A57-A571-D4037BD605DEQ83961691-9FA61A8C-2C1F-401D-9078-52180906D187
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-8326-1921
@en
name
Dimitry M Danilenko
@ast
Dimitry M Danilenko
@en
Dimitry M Danilenko
@nl
type
label
Dimitry M Danilenko
@ast
Dimitry M Danilenko
@en
Dimitry M Danilenko
@nl
prefLabel
Dimitry M Danilenko
@ast
Dimitry M Danilenko
@en
Dimitry M Danilenko
@nl
P106
P21
P31
P496
0000-0002-8326-1921